Aptevo Therapeutics is a biotechnology company focused on oncology (cancer) and hematology (blood disease) therapeutics. The company's core technology is the ADAPTIR? (modular protein technology) platform. The company's product candidates include: APVO436, an ADAPTIR bispecific immunotherapeutic protein targeting CD123, a cell surface receptor expressed on several hematological malignancies and CD3, a component of the T-cell receptor; APVO210, an anti-inflammatory molecule engineered using the company's ADAPTIR platform technology; and ALG.APV-527, a bispecific antibody candidate, featuring a mechanism of action designed to target 4-1BB (CD137) and 5T4, a tumor antigen overexpressed in various types of cancer.

Babcock & Wilcox Enterprises is a technology-based provider of steam production from fossil and renewable sources. The company's segments are: Babcock & Wilcox, which focuses on the supply of, and aftermarket services for, steam-generating, environmental, and auxiliary equipment for power generation and other industrial applications; Volund & Other Renewable, which provides steam-generating systems, environmental and auxiliary equipment for the waste-to-energy and biomass power generation industries, and plant operations and maintenance services for its systems and equipment; and SPIG S.p.A. (SPIG), which provides custom-engineered cooling systems, services and aftermarket products.

BlueLinx Holdings is a distributor of building and industrial products. The company operates its distribution business through a network of distribution centers. The company serves various metropolitan areas in the U.S. The company distributes products in two principal categories: structural products and specialty products. Structural products include plywood, oriented strand board, rebar and remesh, lumber, spruce and other wood products primarily used for structural support, walls, and flooring in construction projects. Specialty products include engineered wood products, moulding, siding (including vinyl products), cedar, metal products (excluding rebar and remesh) and insulation.

Capital Senior Living is an operator of senior housing communities. The company provides senior living services, including independent living services, which are provided to seniors who do not yet need assistance, but who prefer the physical and psychological comfort of a residential community that provides health care and other services; assisted living services, which include personal care services, 24-hour staffing, support services, and supplemental services; and memory care services, which maintain programs and living accomodations for residents with certain forms of dementia. The company makes home care services available to clients at its senior housing communities through third-party providers.

Central Federal is a bank holding company and financial holding company. Through its wholly owned subsidiary, CFBank, National Association (CFBank), the company provides personalized Business Banking products and services including commercial loans and leases, commercial and residential real estate loans and treasury management depository services. In addition, CFBank provides residential lending and retail banking services and products. CFBank provides a variety of deposit accounts with a range of interest rates and terms including savings accounts, retail and business checking accounts, money market accounts and certificates of deposit.

Collegium Pharmaceuticals is a pharmaceutical company focused on pain management. The company's lead product, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the U.S. Food and Drug Administration for the management of pain. The company's product portfolio also includes Nucynta ER, an extended-release formulation of tapentadol for the management of pain including neuropathic pain associated with diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate-release formulation of tapentadol that is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults.

Conifer Holdings is an insurance holding company. Through its insurance company subsidiaries, the company is engaged in the sale of property and casualty insurance products. The company underwrites a variety of specialty insurance products, including property, general liability, commercial multi-peril, and liquor liability, among others. The company organizes its operations in two insurance businesses: commercial insurance lines and personal insurance lines. Through its commercial insurance lines, the company provides coverage for both commercial property and commercial liability. Through its personal insurance lines, the company provides homeowners insurance and dwelling fire insurance products to individuals in several states.

Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing the company's patented piezo-print delivery technology, branded the Optejet?. The company's MicroStat is a fixed combination formulation of phenylephrine-tropicamide for mydriasis (pupil dilation). MicroPine is a topical therapy for the treatment of progressive myopia. MicroProst is a latanoprost formulation for lowering intraocular pressure in patients with ocular hypertension, primary open angle glaucoma, and chronic angle closure glaucoma. MicroTears is the company's over-the-counter product candidate for hyperemia (red eye), pruritis (itch) and dry eye.

Frequency Electronics is engaged in precision time and frequency generation technology. The company's segments are: FEI-NY and FEI-Zyfer. The FEI-NY segment includes the operations of the company's wholly-owned subsidiaries, FEI-Asia and FEI-Elcom. FEI-Asia functions as a manufacturing facility for FEI-NY and FEI-Zyfer. FEI-Elcom provides design and technical support for the FEI-NY segment's business. The FEI-Zyfer segment designs and manufactures products which incorporate global positioning systems technologies and clocks designed and manufactured at FEI-NY. FEI-Zyfer sells its products to both commercial and U.S. Government customers and collaborates with FEI-NY on joint product development activities.

G-III Apparel Group designs, sources and markets a range of apparel, including outerwear, dresses, sportswear, swimwear, women's suits and women's performance wear, women's handbags, footwear, small leather goods, cold weather accessories and luggage. The company has two segments: wholesale operations, which includes sales of products under brands licensed by the company from third parties and sales of products under its own brands and private label brands, and sales related to the Vilebrequin business; and retail operations, which consists of the company's Wilsons Leather, G.H. Bass and DKNY stores operated as outlet stores, and a limited number of Calvin Klein Performance and Karl Lagerfeld Paris stores.

Harley-Davidson is the parent company of Harley-Davidson Motor Company (HDMC) and Harley-Davidson Financial Services (HDFS). The company's segments are: Motorcycles and Related Products, which consists of HDMC that designs, manufactures and sells Harley-Davidson motorcycles as well as motorcycle parts, accessories, general merchandise and services; and Financial Services, which consists of HDFS that is engaged in the business of financing and servicing wholesale inventory receivables and retail consumer loans, primarily for the purchase of Harley-Davidson motorcycles. HDFS also provides motorcycle insurance and protection products to motorcycle owners.

Inuvo is an internet advertising technology and digital publishing company that develops technology to deliver content and advertisements over the internet. The company has two segments: Partner Network, which recruits online publishers and provides them an advertising delivery service, the primary brands for which are ValidClick and SearchLinks©; and Owned and Operated Network, which designs, builds and markets consumer websites and applications, and is consists of the company's main online property marketed under the ALOT brand and a number of other websites targeted at demographics like EARNSPENDLIVE and sites designed for generating leads in a specific market vertical like ASKTHIS for automotive.

Libbey is engaged in the design, production and sale of tableware and other products. The company's products include glassware products, glass tableware, ceramicware, metalware and other tabletop products. Glass tableware products include products such as tumblers, stemware, mugs, bowls, vases, salt and pepper shakers, shot glasses, canisters, candleholders and other items. Other glass products include storageware, serveware, bakeware, handmade glass tableware and components such as blender jars and mixing bowls sold to original equipment manufacturers. The company also provides a range of ceramic dinnerware products. These include plates, bowls, platters, cups, saucers and other tabletop accessories.

Marchex is a call analytics company that helps businesses connect, drive, measure and convert callers into customers. The company's primary product offerings include: Marchex Call Analytics, which is an analytics platform for enterprises; Marchex Display and Video Analytics, which is a product for marketers that buy digital display advertising; Marchex Site Analytics, which is a product for marketers that can drive phone calls from websites; Marchex Social Analytics, which is a product for marketers that buy social media advertising; Marchex Call Marketplace, which is a mobile advertising network for businesses; and Local Leads, which is an advertising solution for small business resellers.

Motus GI Holdings is a development stage company. The company has developed the Pure-Vu system, a medical device. The Pure-Vu System is indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard and slim colonoscopes to enable cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter.

MVB Financial is a financial holding company. Through its subsidiaries, the company provides community banking and mortgage banking. The company's subsidiary, MVB Bank, Inc. (The Bank), provides products and services, including: demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; commercial, consumer, and real estate mortgage loans and lines of credit; cashier's checks; safe deposit rental facilities; and non-deposit investment services. The Bank's financial products and services are provided through its financial service locations and automated teller machines, as well as telephone and internet-based banking through both personal computers and mobile devices.

Otelco provides a range of telecommunication services on a retail and wholesale basis. These services include local and long distance calling; network access to and from the company's customers; data transport; digital high-speed internet; cable and Internet Protocol television; other telephone related services; and cloud hosting and managed services. The company provides various communications services that are sold to economically similar customers in a comparable manner of distribution. The company also provides cloud hosting and managed services for small and mid-sized companies who rely on mission-critical software applications.

Savara is an orphan lung disease company. The company's drug development pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor in development for pulmonary alveolar proteinosis and in development for nontuberculous mycobacterial lung infection; and AeroVanc, an inhaled vancomycin for treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis.

Soleno Therapeutics is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company's primary candidate, Diazoxide Choline Controlled Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company's research and development efforts are primarily focused on developing its primary candidate, DCCR tablets for the treatment of PWS, through late-stage clinical development.

Solid Biosciences is engaged in the treatment of Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys, with symptoms that manifest between three and five years of age. The company's primary gene transfer candidate, SGT-001 is designed to address the underlying genetic cause of DMD by delivering a synthetic transgene that produces dystrophin-like protein that is only expressed in muscles of the body, including cardiac and respiratory muscles. The company's portfolio also includes an initial disease modifying candidate, Anti-LTBP4, a monoclonal antibody designed to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein.

Vermillion is engaged in the discovery, development and commercialization of diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women. The company concentrates its development of diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer. The company's primary product, OVA1, is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high risk of having a malignant ovarian tumor prior to planned surgery. The company's ASPiRA LABS engages in applying biomarker-based technologies to address needs in the management of gynecologic cancers and disease.

Zuora is a cloud-based subscription management platform. The company's solution is the system of record for its customers' subscription business models and consists of three components: the company's Zuora Central Platform, which platform acts as an intelligent subscription management hub, allowing customers to orient operations around it to create a process designed for subscription business models; other products, which consists of Zuora Billing and Zuora RevPro; and an application marketplace, which the Zuora Marketplace provides industry-specific tools and third-party applications that extend the company's capabilities for its customers.